Invention Application
- Patent Title: Pharmaceutical Composition Containing Carbohydrate Modifying Enzyme and Method of Curing Dendritic Cell Immunoreceptor-Related Disease Using Pharmaceutical Composition
-
Application No.: US16611883Application Date: 2018-05-14
-
Publication No.: US20200261552A1Publication Date: 2020-08-20
- Inventor: Yoichiro IWAKURA , Tomonori KAIFU
- Applicant: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
- Applicant Address: JP Tokyo
- Assignee: Tokyo University of Science Foundation
- Current Assignee: Tokyo University of Science Foundation
- Current Assignee Address: JP Tokyo
- International Application: PCT/JP2018/018610 WO 20180514
- Main IPC: A61K38/47
- IPC: A61K38/47 ; A61P37/06 ; A61P19/02
Abstract:
Provided are: a pharmaceutical composition for curing, treating, or preventing a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor, in which the pharmaceutical composition contains a carbohydrate modifying enzyme as an active ingredient; and a method of curing, treating, or preventing a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor.
Public/Granted literature
Information query
IPC分类:
